Insider Trading May 6, 2026 09:13 PM

General Atlantic Increases Stake in Alkami Technology via $34.7 Million Equity Purchase

Investment funds affiliated with the major shareholder acquired over 2 million shares amidst recent volatility and mixed quarterly results.

By Nina Shah ALKT

In a series of open market transactions occurring between May 4 and May 6, 2026, investment funds linked to General Atlantic, L.P. significantly increased their position in Alkami Technology, Inc. (NASDAQ:ALKT). The cumulative acquisition totaled approximately $34.7 million for over 2 million shares of common stock. This move comes as the company navigates a period of price depreciation and recent earnings volatility, even as it maintains robust revenue growth and positive analyst projections for future profitability.

General Atlantic Increases Stake in Alkami Technology via $34.7 Million Equity Purchase
ALKT

Key Points

  • General Atlantic, L.P. significantly expanded its ownership in Alkami Technology through $34.7 million in purchases over three days.
  • Despite a 27% year-to-date drop in share price, the company is showing strong revenue growth of 33%.
  • Analyst projections suggest a transition from a current $0.47 per share loss to an expected profit of $0.80 EPS this year.
  • The fintech and financial technology sectors are impacted by these movements as institutional confidence is tested against earnings volatility.

Investment funds associated with General Atlantic, L.P., which maintains a significant role as both a major shareholder and a director-by-deputization for Alkami Technology, Inc. (NASDAQ:ALKT), have executed a substantial series of stock purchases. Over a three-day period in early May 2026, these affiliated entities acquired more than 2 million shares of the company's common stock, representing an investment totaling roughly $34.7 million.

The acquisition process was structured across three specific dates, each involving different transaction volumes and price points:

  • May 4, 2026: The reporting entities secured 521,771 shares at a weighted average price of $16.92 per share. During this session, individual transaction prices fluctuated between $16.67 and $17.18.
  • May 5, 2026: A further 700,000 shares were purchased at a weighted average of $16.84 per share, with trading prices ranging from $16.69 to $16.96.
  • May 6, 2026: The final phase of the buying spree saw the acquisition of 844,772 shares at a weighted average price of $16.63 per share, with prices recorded between $16.60 and $16.68.

In total, these open market purchases accounted for 2,066,543 new shares for the General Atlantic-affiliated funds. Following these transactions, the indirect holdings of the reporting persons have risen to a combined total of 17,445,994 shares of Alkami Technology common stock. This position represents a major stake in the company, which currently holds a market capitalization of $1.77 billion. The ownership is distributed among various General Atlantic investment funds as noted in recent filings.


The timing of this capital injection coincides with a challenging period for Alkami's share price. Currently trading near $16.75, the stock has experienced a 27% decline year-to-date and is sitting approximately 47% below its 52-week high of $31.66. Despite these market pressures, certain fundamental indicators remain noteworthy. The company has demonstrated strong revenue growth of 33% and maintains a solid balance sheet position. Furthermore, analyst forecasts suggest a potential shift in the company's financial trajectory, predicting profitability this year with an expected earnings per share (EPS) of $0.80, which would mark a substantial improvement from the current loss of $0.47 per share.

However, recent quarterly performance highlights a complex financial landscape for the firm. For the first quarter of 2026, Alkami Technology reported mixed results. While revenue reached $126.1 million—exceeding the anticipated $125.24 million by 0.69%—the company's earnings per share came in at -$0.09. This figure missed the forecasted EPS of $0.18, representing a significant negative surprise of 150%. At this time, there have been no reported major mergers or acquisitions, nor have any analyst upgrades or downgrades been noted for the company.

Risks

  • Earnings Volatility: The company reported a 150% negative surprise in EPS for Q1 2026, missing expectations significantly.
  • Market Valuation Pressure: Alkami's stock is currently trading nearly 47% below its 52-week high, reflecting recent downward trends in the equity markets.
  • The technology and financial services sectors may face uncertainty if revenue gains do not translate into meeting bottom-line earnings projections.

More from Insider Trading

Delek US Holdings Director Ezra Uzi Yemin Executes $1.6 Million Stock Sale May 6, 2026 Hilltop Holdings Chief Accounting Officer Executes Stock Sale May 6, 2026 General Atlantic Affiliates Execute $34.6 Million Equity Acquisition in Alkami Technology May 6, 2026 Magnetar-Linked Entities Liquidate $44.6 Million in CoreWeave (CRWV) Equity May 6, 2026 Magnetar-Affiliated Funds Liquidate $124.96 Million in CoreWeave Class A Shares May 6, 2026